Physician profile
Monara Dini
NPI 1891097655
$15,815.39
in general payments reported to CMS, 2019-2025
41 companies · $953 in 2025
The $953 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,883 · 2020: $779 · 2021: $1,427 · 2022: $575 · 2023: $7,839 · 2024: $2,359 · 2025: $953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,171 · Travel and Lodging: $1,960 · Education: $20.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,171.18 |
| Travel and Lodging | $1,960.19 |
| Education | $20.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Epsfl, LLC | $5,169.99 | 2023 | |
| Treace Medical Concepts, INC. | $1,612.70 | 2022-2025 | |
| Smith+Nephew, INC. | $1,612.31 | 2019-2025 | Renasys Go V2 Home, Pico, Grafix Pl |
| Paragon 28, INC. | $1,302.20 | 2021-2024 | Portfolio, Phantom Metatarsal Shortening, Mtp |
| Voom Medical Devices, INC. | $682.63 | 2024 | Revcon |
| Alafair Biosciences, INC. | $452.57 | 2024 | Versawrap |
| Osiris Therapeutics INC. | $441.04 | 2019 | |
| Stryker Corporation | $415.35 | 2019-2024 | Prostep Mica, Ortholoc 2 Lapifuse, Core |
| Integra Lifesciences Corporation | $370.87 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $361.99 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Surgiclose |
| Exactech, INC. | $344.41 | 2024-2025 | |
| Organogenesis INC. | $307.17 | 2020-2023 | Puraply |
| Medline Industries LP | $301.85 | 2019-2022 | |
| Tactile Systems Technology INC | $297.64 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Nevro Corp. | $223.15 | 2022-2024 | Senza |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $206.88 | 2021-2024 | Physio-Stim, Accelstim |
| Curonix LLC | $162.01 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Crossroads Extremity Systems, LLC | $151.99 | 2021 | |
| Derma Sciences, INC. | $145.71 | 2019 | |
| Paratek Pharmaceuticals, INC. | $143.77 | 2025 | Nuzyra |
| Musculoskeletal Transplant Foundation INC. | $137.47 | 2020-2021 | |
| Depuy Synthes Sales INC. | $120.58 | 2019 | |
| Evolution Surgical, INC | $112.70 | 2023-2024 | |
| Bioventus LLC | $104.15 | 2020-2024 | Exogen Ultrasound Bone Healing System |
| Wright Medical Technology, INC. | $72.07 | 2019 | |
| Axogen | $61.41 | 2023 | Avance Nerve Graft |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.57 | 2020 | |
| Averitas Pharma INC. | $48.94 | 2023-2024 | Qutenza |
| Access Pro Medical, LLC | $47.33 | 2025 | Matriderm |
| Urgo Medical North America, LLC | $38.93 | 2025 | Urgok2 |
| Bone Support INC. | $36.93 | 2025 | Ceramentbone Void Filler, Cerament G |
| Amgen INC. | $36.89 | 2019-2020 | |
| Acell, INC. | $36.63 | 2019 | |
| Aroa Biosurgery Incorporated | $36.60 | 2024 | |
| Abbott Laboratories | $29.36 | 2019 | |
| Horizon Therapeutics Plc | $29.31 | 2020 | |
| Globus Medical, INC. | $28.00 | 2025 | Senza |
| Polarityte, INC. | $25.70 | 2020 | |
| Merck Sharp & Dohme LLC | $17.34 | 2019 | |
| Zimmer Biomet Holdings, INC. | $17.30 | 2020 | |
| Ovik Health, LLC | $15.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monara Dini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.